Related references
Note: Only part of the references are listed.Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Xin Yin et al.
CELL REPORTS (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Andrew I. Ritchie et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping et al.
CELL (2020)
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Aymeric Silvin et al.
CELL (2020)
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
Runhong Zhou et al.
IMMUNITY (2020)
Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients
Linnan Zhu et al.
IMMUNITY (2020)
Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area
Farhaan S. Vahidy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Comprehensive mapping of immune perturbations associated with severe COVID-19
Leticia Kuri-Cervantes et al.
SCIENCE IMMUNOLOGY (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi et al.
NATURE COMMUNICATIONS (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
Guillaume Carissimo et al.
NATURE COMMUNICATIONS (2020)
Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection
Lerato N. Ndlovu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness
Zuzana Parackova et al.
CELLS (2020)
Immune suppression in the early stage of COVID-19 disease
Wenmin Tian et al.
NATURE COMMUNICATIONS (2020)
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Vincenzo Bronte et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Fine-Tuning of Type I Interferon Response by STAT3
Ming-Hsun Tsai et al.
FRONTIERS IN IMMUNOLOGY (2019)
STAT3 Regulates the Type I IFN-Mediated Antiviral Response by Interfering with the Nuclear Entry of STAT1
Huanru Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult
Tyler J. Loftus et al.
CURRENT OPINION IN HEMATOLOGY (2018)
STAT3 roles in viral infection: antiviral or proviral?
Zhangmei Chang et al.
FUTURE VIROLOGY (2018)
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow
Mikael Roussel et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
STAT3 signaling in immunity
Emily J. Hillmer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Sepsis and septic shock
Richard S. Hotchkiss et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3
Emma M. Haapaniemi et al.
BLOOD (2015)
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Sarah E. Flanagan et al.
NATURE GENETICS (2014)
Demand-adapted regulation of early hematopoiesis in infection and inflammation
Hitoshi Takizawa et al.
BLOOD (2012)
STAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response
Wei-Bei Wang et al.
JOURNAL OF IMMUNOLOGY (2011)
Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction
Hideki Ogura et al.
IMMUNITY (2008)
Share Paper
